Hong Kong SAR
-
China’s Jinxin Fertility Group has raised HK$2.99bn ($381.9m) from its Hong Kong listing after riding a wave of investor demand for healthcare stocks.
-
Cooley has appointed capital markets lawyer Michael Yu as a partner in Hong Kong, as the firm continues ramping up its Asia presence.
-
Xinyi Glass Holdings and Xinyi Group (Glass) Co sealed a HK$1.18bn ($150.3m) block trade of Xinyi Solar Holdings' shares on Monday after a lock-up expired on their positions in the company.
-
Alibaba Group Holding’s board of directors has begun preparations for a planned IPO of up to $20bn in Hong Kong, proposing a stock split that will give the company flexibility for future capital market activities.
-
Shanghai Junshi Biosciences’ shareholders have given the green light to the firm’s proposal to float primary stock on Shanghai’s new Nasdaq-style board, according to an exchange filing.
-
In this round-up, the Mainland’s industrial production and other activity slowed in May, the Chinese foreign ministry urged the US to stop interfering with the country’s ‘internal affairs’ and the People’s Bank of China (PBoC) tried to calm the market again regarding Baoshang Bank’s bailout.
-
China’s Ascentage Pharma Group International and CIMC Vehicles kicked off pre-marketing for their respective Hong Kong IPOs on Monday. Both are expected to launch bookbuilding by the end of June.
-
Chinese components manufacturer Impro Precision Industries has opened books for its HK$1.1bn ($140.49m) IPO after receiving Hong Kong Stock Exchange approval for its float.
-
Budweiser Brewing Company Apac, the Asia Pacific arm of Belgian brewer AB InBev, has put the wheels in motion for a float of up to $10bn on the Hong Kong Stock Exchange.
-
In this round-up, US president Donald Trump warned of higher tariffs should his Chinese counterpart not meet him at G20, UBS’s chief economist employed questionable language when discussing the rise of Chinese consumer prices, and total exports edged up in May while exports to the US fell again.
-
In this round-up, Pan Gongsheng, vice governor of the People’s Bank of China, suggests cancelling quota limits for the Qualified Foreign Institutional Investor (QFII) scheme, the National Development and Reform Commission (NDRC) heightened scrutiny on offshore bond issuers, and the Hong Kong Insurance Authority prepares the ‘Mainland-Hong Kong Insurance Connect’.
-
ESR Cayman, which builds and leases warehouses, has pulled its float on the Hong Kong Stock Exchange, delaying the deal indefinitely.